Le Lézard
Classified in: Health
Subjects: PDT, STP

Minnesota Medical Solutions Launches Digital Advocacy Campaign


MINNEAPOLIS, March 9, 2020 /PRNewswire/ -- Minnesota Medical Solutions, LLC ("MinnMed" or "the Company") today announced the launch of a digital advocacy campaign to engage Minnesotans and gain support among lawmakers to add dry flower products to the state's medical cannabis program. By adding dry flower cannabis products, Minnesota can increase the accessibility and affordability of medical cannabis products for thousands of Minnesotans.

"While Minnesota's medical cannabis program has seen tremendous advancements over the last few years, affordability remains a major challenge for many Minnesotans," said MinnMed Founder, Kyle Kingsley, M.D. "Allowing cannabis to be sold as dry flower is an easy decision that will bring great benefit to Minnesota's medical cannabis program and its patients."

Of the 33 states that have legalized medical cannabis, Minnesota is one of the few that does not allow dry flower medical cannabis. For the more than 18,000 certified patients enrolled in the program, the lack of availability of flower has meant Minnesota patients face some of the highest medical cannabis costs in the nation ? a cost that cannot be covered by medical insurance.

"We're proud to be a leading voice in advocating for improvements to the state's medical cannabis program," said Dr. Kingsley. "We are asking our patients and their families to join us in taking action to get dry flower added to the state's program by writing or calling their legislators."

Interested advocates can learn more about MinnMed's campaign and quickly send emails, texts, or social posts to their legislators by visiting https://minnesotamedicalsolutions.com/advocacy/

About Minnesota Medical Solutions
Minnesota Medical Solutions, LLC ("MinnMed") is one of two licensed medical cannabis companies in Minnesota. MinnMed operates four Cannabis Patient Centers across the state and a greenhouse facility near Otsego, MN. MinnMed is a subsidiary of Vireo Health International, Inc. ("Vireo"). Vireo's mission is to build the cannabis company of the future by bringing the best of medicine, engineering and science to the cannabis industry.  Vireo's physician-led team of more than 400 employees provides best-in-class cannabis products and customer experience. For more information about MinnMed, please visit www.minnmed.com

Contact Information

Media Inquiries
Albe Zakes
Vice President, Corporate Communications
[email protected]  
(267) 221-4800          

 

SOURCE Minnesota Medical Solutions


These press releases may also interest you

at 02:48
Today, RaySearch Laboratories AB (publ)  publishes its Annual Report for the financial year 2023. The report is held available on RaySearch's website, under the section Investors.  This information is information that RaySearch Larboratiories AB...

at 02:43
Shareholders of Zinzino AB (publ) are hereby invited to the annual general meeting on Monday, May 27, 2024, at 1:30 PM at the company's premises at Hulda Mellgrens gata 5 in Gothenburg. Registration begins at 1:15 PM. The company aims to webcast the...

at 02:41
Implantica AG (publ), a med-tech company at the forefront of bringing advanced technology into the body, is publishing its annual report for the fiscal year 2023. The annual report is now available on the company's website. "Implantica had a very...

at 02:08
Revenue amounted to ?498.8m (?419.3m), an increase of 18.9% with an organic growth of 14.2%.Operating profit (EBIT) was ?19.0m (?10.7m), an increase of 78.0%, representing an operating margin of 3.8% (2.6%).Net profit amounted to ?6.5m (?2.1m), which...

at 02:00
Amwins Global Risks is delighted to announce Classic Cars and Cotswolds, an auction to raise money for the Matthew Wilson Multiple Myeloma Fund at Blood Cancer UK. The online auction opens today and features Ferraris, Aston Martins, a Rolls Royce, a...

at 01:35
Regulatory News: Sensorion (FR0012596468 ? ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, today announces...



News published on and distributed by: